Characterization of outcomes in patients with metastatic non-small cell lung cancer treated with programmed cell death protein 1 inhibitors past RECIST version 1.1–defined disease progression in clinical trials

Title
Characterization of outcomes in patients with metastatic non-small cell lung cancer treated with programmed cell death protein 1 inhibitors past RECIST version 1.1–defined disease progression in clinical trials
Authors
Keywords
Treatment beyond progression, Non-small cell lung carcinoma, PD-1 inhibitor, Immunotherapy
Journal
SEMINARS IN ONCOLOGY
Volume 44, Issue 1, Pages 3-7
Publisher
Elsevier BV
Online
2017-02-11
DOI
10.1053/j.seminoncol.2017.01.001

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now